Improved prediction of smoking status via isoform-aware RNA-seq deep learning models.

Journal: PLoS computational biology
PMID:

Abstract

Most predictive models based on gene expression data do not leverage information related to gene splicing, despite the fact that splicing is a fundamental feature of eukaryotic gene expression. Cigarette smoking is an important environmental risk factor for many diseases, and it has profound effects on gene expression. Using smoking status as a prediction target, we developed deep neural network predictive models using gene, exon, and isoform level quantifications from RNA sequencing data in 2,557 subjects in the COPDGene Study. We observed that models using exon and isoform quantifications clearly outperformed gene-level models when using data from 5 genes from a previously published prediction model. Whereas the test set performance of the previously published model was 0.82 in the original publication, our exon-based models including an exon-to-isoform mapping layer achieved a test set AUC (area under the receiver operating characteristic) of 0.88, which improved to an AUC of 0.94 using exon quantifications from a larger set of genes. Isoform variability is an important source of latent information in RNA-seq data that can be used to improve clinical prediction models.

Authors

  • Zifeng Wang
    Department of ECE, Northeastern University, Boston, Massachusetts, United States.
  • Aria Masoomi
    Department of ECE, Northeastern University, Boston, Massachusetts, United States.
  • Zhonghui Xu
    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States.
  • Adel Boueiz
    Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Sool Lee
    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States.
  • Tingting Zhao
    School of Software Engineering, Beihang University, Beijing, China.
  • Russell Bowler
    Division of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, Colorado, United States.
  • Michael Cho
    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States.
  • Edwin K Silverman
    Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Craig Hersh
    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States.
  • Jennifer Dy
    Department of Electrical and Computer Engineering, Northeastern University, Boston, Massachusetts.
  • Peter J Castaldi
    Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; General Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: repjc@channing.harvard.edu.